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Objectives This study sought to compare the diagnostic performance of a multidetector computed tomography (MDCT) inte-
grated protocol (IP) including coronary angiography (CTA) and stress-rest perfusion (CTP) with cardiac magnetic
resonance myocardial perfusion imaging (CMR-Perf) for detection of functionally significant coronary artery dis-
ease (CAD).
Background MDCT stress-rest perfusion methods were recently described as adjunctive tools to improve CTA accuracy for
detection of functionally significant CAD. However, only a few studies compared these MDCT-IP with other clini-
cally validated perfusion techniques like CMR-Perf. Furthermore, CTP has never been validated against the inva-
sive reference standard, fractional flow reserve (FFR), in patients with suspected CAD.
Methods 101 symptomatic patients with suspected CAD (62  8.0 years, 67% males) and intermediate/high pre-test
probability underwent MDCT, CMR and invasive coronary angiography. Functionally significant CAD was defined
by the presence of occlusive/subocclusive stenoses or FFR measurements 0.80 in vessels 2mm.
Results On a patient-based model, the MDCT-IP had a sensitivity, specificity, positive and negative predictive values of 89%,
83%, 80% and 90%, respectively (global accuracy 85%). These results were closely related with those achieved by
CMR-Perf: 89%, 88%, 85% and 91%, respectively (global accuracy 88%). When comparing test accuracies using non-
inferiority analysis, differences greater than 11% in favour of CMR-Perf can be confidently excluded.
Conclusions MDCT protocols integrating CTA and stress-rest perfusion detect functionally significant CAD with similar accu-
racy as CMR-Perf. Both approaches yield a very good accuracy. Integration of CTP and CTA improves MDCT per-
formance for the detection of relevant CAD in intermediate to high pre-test probability populations. (J Am Coll
Cardiol 2013;61:1099–107) © 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.12.020Multidetector computed tomography (MDCT) is the es-
tablished noninvasive reference standard for the assessment
of coronary artery anatomy. It is particularly useful for the
exclusion of coronary artery disease (CAD) in patients with
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erally involves additional studies,
as the degree of stenosis is often
overestimated and the physio-
logic significance of many lesions
remains uncertain (4,5). Further-
more, its diagnostic accuracy is
severely limited by calcification,
reducing the value in patients with
higher pre-test probability. In those
cases, it is generally preferable to use
functional tests, capable of detecting
myocardial ischemia (6).
MDCT perfusion (CTP) has
been recently described as a poten-
tial tool for ischemia detection and
preliminary studies proved the in-
cremental value of integrating
CTP and CTA for the detection
of obstructive CAD as assessed by
invasive x-ray coronary angiogra-
phy (xA) in high-risk populations
(7,8). However, a comparison of
these MDCT integrated protocols (MDCT-IP) with established
stress perfusion techniques like cardiovascular magnetic resonance
(CMR) myocardial perfusion imaging (Perf) (9–11) and frac-
tional flow reserve (FFR), considered the invasive standard for
assessing the functional significance of CAD (12) is missing.
The aim of this study was to compare the diagnostic
accuracy of a MDCT-IP (including CTA and stress-rest
myocardial CTP) with CMR-Perf for the detection of
functionally significant CAD, using FFR as the reference
standard.
Methods
Population. One-hundred-seventy-six consecutive pa-
ients referred to the cardiology outpatient clinic for assess-
ent of CAD were prospectively screened from January
010 to November 2011. Inclusion criteria were: age 40
ears, symptoms compatible with CAD and 2 risk-factors
r a positive/inconclusive treadmill-test. Exclusion criteria
ncluded clinical instability, known CAD, valvular heart
isease, atrial fibrillation, creatinine clearance 60 ml/min
nd standard contraindications to CMR, contrast media
nd adenosine. A total of 139 eligible patients were tested
or exclusion criteria. Figure 1 summarizes the study flow
and reasons for exclusions. The final population consisted of
101 individuals with an intermediate or high pre-test
probability (Table 1) (13). The local research ethics com-
mittee approved the study protocol and written informed
consent was obtained from all participants.
Study design. Patients were scheduled for CMR and
MDCT scans in the week before xA and were instructed to
refrain from smoking, coffee, tea, aminophylline, beta-
Abbreviations
and Acronyms
CAD  coronary artery
disease
CMR  cardiac magnetic
resonance
CTA  computed
tomography angiography
CTP  computed
tomography perfusion
FFR  fractional flow
reserve
IP  integrated protocol
MDCT  multidetector
computed tomography
Perf  myocardial perfusion
imaging
NPV  negative predictive
value
PPV  positive predictive
value
xA  x-ray coronary
angiographyblockers, calcium antagonists and nitrates for 24-h before dthe tests. At the time of xA, FFR was measured in all major
patent coronary arteries with 40% diameter stenosis.
CMR and MDCT results were fully blinded.
CMR protocol. CMR-Perf was performed using estab-
lished protocols on a 1.5-T Siemens Symphony (Siemens,
Erlangen, Germany) using a 12-channel receiver coil (14).
Three short-axis slices (basal, mid-ventricular, apical) per
heartbeat were imaged at apnoea during the first pass of a
gadolinium bolus (0.07 mmol/kg) using a gradient-echo
sequence during maximal hyperemia (intravenous adenosine
140 g·kg1·min1) and at rest. Long- and short-axis
cinematic images were obtained using a steady-state free-
precession breath-hold sequence for volumetric and func-
tional analyses. Late-gadolinium-enhancement imaging
(LGE) using a 2D phase-sensitive inversion-recovery
breath-hold sequence was performed 10 min after the last
administration of contrast (11).
MDCT scan protocol. The MDCT stress-rest protocol
was performed as previously described, using a Somatom
Sensation 64 scanner (Siemens Medical Solutions, Forch-
heim, Germany) (15). No pre-test medication was
administered.
After calcium-scoring, a retrospectively gated scan during
the first-passage of contrast medium (iopromide, 80 ml, at
4.5 ml/s) during adenosine infusion (140 g·kg1·min1
for 3 to 6 min) was obtained (tube voltage: 100 kV; tube
current modulation with full tube current [600 mAs] ap-
plied at 60% to 65% of the RR interval; collimation, 64 
0.6 mm) using a bolus-tracking technique in the ascending
aorta (threshold: 150 HU; delay, 4 s). Adenosine infusion
was discontinued immediately after stress acquisition.
If the heart rate exceeded 65 beats/min at 3 min after
suspension of adenosine (n  44), fractionated boluses of
ntravenous metoprolol (5 to 20 mg) were administered
argeting a heart rate 60 beats/min. All patients received
.05 mg of sublingual nitroglycerine 5 min prior to the rest
can. This scan was acquired 10 min after the stress scan,
sing prospective triggering (65% of cardiac cycle interval;
00 kV; 110 mAs). Timing and contrast injection were
imilar to the stress scan, using a test-bolus technique.
MR analysis. Two blinded independent readers analysed
ll CMR images. In cases of disagreement, a third reader
djudicated. Perfusion defects were defined as subendocar-
ial or transmural dark areas compared to remote healthy
yocardium, persisting for at least 10 frames. Stress and rest
cans were viewed simultaneously, and areas of hypoperfu-
ion were assigned to the ventricular segments, using the
tandard 17-segment model, excluding the apex (16). LGE
as analysed simultaneously and used to differentiate areas
f scar from induced ischemia. Regional wall motion or scar
lone was not regarded as a sign of ischemia/CAD. Only
reas with ischemia on perfusion imaging were regarded as
ositive; patients with scar but no additional ischemia were
lassified as negatives. Image quality and degree of confi-
ence were classified using four-class scales: from poor to
1101JACC Vol. 61, No. 10, 2013 Bettencourt et al.
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respectively.
MDCT analysis. For CTA analysis both stress and rest
acquisitions were used. From the stress acquisition, a set of
10 (5% to 95%) plus 1 (60%) phases was reconstructed using
a standard soft frequency cardiac filter (Siemens-B25f), with
a slice-thickness of 0.6mm. From rest, a single-phase (65%)
reconstruction was obtained using the same slice thickness
and filter. Resulting datasets were anonymized, sent to a
post-processing workstation (Aquarius; TeraRecon Inc.,
San Mateo, California) and analyzed by two blinded readers
using the 17-segment modified AHA classification (17).
Each segment was graded according to stenoses: 1 
normal; 250%; 3 50% to 70%; 470%/occlusion;
5  uninterpretable.
For myocardial CTP analysis, similar reconstructions
were obtained using the same parameters but with a very
smooth frequency filter (Siemens-B10f). The same blinded
readers performed a visual analysis of these images at a
Figure 1 Study Flow Chart and Reasons for Exclusions
Of the 176 screened patients, 139 met inclusion criteria; of those, 15 had exclus
not completing the protocol as planned. The 101 patients composing the final po
graphy (MDCT), and coronary catheterization with no adverse events. CAD  corondifferent time point of the study, according to the standard17-segment model (16) using standard 10-mm-thick mul-
tiplanar reformat planes (short-axis, 2, 3, and 4 chambers).
This analysis was typically initiated using average intensity
projections and set to narrow window (W) and level (L)
settings (W300/L150), but the reading physician was al-
lowed to adjust settings and projections, as needed. Stress
images were typically analyzed as cinematic images, taking
advantage of the multiphasic reconstruction and integrating
perfusion with regional wall motion analysis. This approach
helped in the differentiation of perfusion defects from
artifacts, which tend to change position from systole to
diastole. A side-by-side comparison of stress and rest
images was also used to differentiate inducible ischemia
from artifacts or scar. The same criteria used for defining
functionally significant CAD in CMR-Perf analysis were
applied for CTP. Image quality and degree of confidence
were classified as described for CMR. Interobserver dis-
agreements were resolved by consensus.
MDCT radiation exposure estimation. Effective radiation
teria and 11 refused written informed consent. Twelve patients were excluded for
on underwent cardiac magnetic resonance (CMR), multidetector computed tomo-
tery disease; EKG  electrocardiogram; FFR  fractional flow reserve.ion cri
pulati
ary ardose exposure was calculated by the method of the Euro-
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and the dose-length product (DLP) obtained during each
scan (18).
X-ray coronary angiography and FFR assessment. xA
was performed according to standard techniques. When
arteries with stenosis 40% were visually perceived, pres-
sure wire (Certus, St. Jude Medical, St. Paul, Minnesota)
was used to determine vessel FFR by using RadiAnalyzer
(St. Jude Medical, St. Paul, Minnesota) under steady-state
hyperemia (intravenous adenosine, 140 g·kg1·min1, 3
to 6 min). Arteries were recorded as having significant CAD
if they had a FFR 0.80, if they were occluded/subtotally
occluded, or if there was severe left main (LM) disease
(50%). This functionally significant CAD was defined as
the reference standard against which MDCT and CMR-
Population Characteristics (N  101)Table 1 Population Characteristics (N  101)
Males (% of total) 68 (67%)
Age (yrs) 62 8.0 (41–79)
Body mass index (kg/m2) 28.0 4.45 (19.9–45.2)
Symptoms 101 (100%)
Typical angina 25 (25%)
Atypical angina 49 (49%)
Chest pain 22 (22%)
Dyspnea on exertion/fatigue 5 (5%)
Hypercholesterolemia 80 (79%)
Hypertension 73 (72%)
Diabetes mellitus 39 (39%)
Positive smoking history 34 (34%)
Current smoker 14 (14%)
Ex-smoker 20 (20%)
Family history of premature CAD 21 (21%)
2 CRF 85 (84%)
Systolic blood pressure (mm Hg) 147 21.9 (99–184)
Diastolic blood pressure (mm Hg) 78 10.8 (57–102)
Abdominal circumference (cm) 98 10.3 (76–126)
Modified Diamond-Forrester score 14.2 2.7 (9–20)
On regular medication 90 (89%)
Aspirin or clopidogrel 54 (53%)
Statin 66 (65%)
ACEi or A2 receptor blockers 52 (51%)
Beta-blocker 68 (67%)
Agatston score (median-min-max) 291 (0–5,879)
CAC  10 19 (19%)
CAC 11–100 20 (20%)
CAC 101–400 17 (17%)
CAC 401–1,000 26 (26%)
CAC 1,000 19 (19%)
Any stenosis 40% 54 (53%)
Any significant stenosis (FFR 0.80) 44 (44%)
Single-vessel disease 24 (24%)
Double-vessel disease 12 (12%)
Triple-vessel disease 8 (8%)
Left main disease 5 (5%)
Values are n (%) or mean  SD (range).
ACEi  angiotensin-converting enzyme inhibitor; A2  angiotensin 2.Perf were compared. sAssignment of perfusion segments to the corresponding
vascular territory. For vessel-based analysis, areas of per-
fusion defects in CTP and CMR were identified using the
16 myocardial segments. Each segment was assigned to one
of the 3 “main vessels”: right coronary artery (RCA), left
anterior descending (LAD), and circumflex (LCX). To
ensure correct association of the 16 myocardial segments
with the correct vascular territory, xA visualization of vessel
dominance was used to decide if the inferior and inferosep-
tal territories were supplied by the RCA or the LCX. For
the distal segment of the inferior wall, an eventual LAD
supply was also considered. Additionally, the basal and mid
anterolateral segments were assigned to the LCX or LAD
vessel depending on whether obtuse marginal or diagonal
branches were responsible for the blood supply of those
territories (16).
Statistical analysis. The diagnostic performances of
MDCT (CTA alone, CTP alone, MDCT-IP) and CMR
for the detection of functionally significant CAD were
compared against FFR as the reference standard. The
“unevaluable” segments/arteries in CTA were coded as
being positive for CAD when CTA alone was considered;
in the MDCT-IP, they were classified as negative or
positive, according to the CTP results of their territory (Fig. 2).
TP performance in detecting reversible myocardial isch-
mia was also evaluated having CMR-Perf as the reference
tandard.
All continuous variables were expressed as mean  SD,
hereas categorical variables were expressed as percentages.
he McNemar test was used to calculate differences be-
ween proportions (sensitivity, specificity and accuracy)
btained from paired observations. Cohen’s kappa statistic
as used to assess intermodality and intra/interobserver
greements. The area under the receiver-operator charac-
eristic curve (AUC  C-statistic) was calculated and
ompared for all diagnostic-testing strategies taking FFR as
old-standard. Specific methods to test noninferiority for
aired binary data (19) and ROC curves (20) were used to
alculate the minimal noninferiority margin that we are able
o detect with the present sample size and to perform a
ormal power analysis. Statistical analyses were performed
sing MedCalc for Windows, version 12.3.0.0 (MedCalc
oftware, Mariakerke, Belgium). A p value 0.05 was
onsidered statistically significant.
esults
ll patients completed the study protocol without adverse
ffects. CMR and MDCT scans were performed within 9
.2 days before xA.
MR scans. Image quality was classified as poor in 2
atients, moderate in 20, good in 57, and excellent in 22.
eaders felt unconfident in the diagnosis of 8 patients,
onfident in 60 and very confident in 33. Forty-six patients
nd 70 of the 303 vascular territories had perfusion defects
uggestive of ischemia during stress (Fig. 3); 30 were in the
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territory. Sixteen patients had an ischemic pattern of LGE.
Intraobserver and interobserver agreements for CMR-Perf
in per-patient analysis produced a kappa of 0.71 and 0.57,
respectively (substantial agreement).
MDCT scans. Image quality was classified as poor in 9
patients, moderate in 39, good in 52 and excellent in 1.
Readers felt unconfident in 49 cases, confident in 47 and
very confident in 5. Mean radiation exposure of the entire
MDCT protocol was 5.0  0.96 (3.7 to 8.9) mSv. Thirty-
hree (33%) patients had at least 1 unevaluable segment –
sually because of the presence of extensive calcification.
mong the patients who had fully interpretable scans, 10
ad no atherosclerotic disease, 25 had mild disease (50%
tenosis), and 33 had stenosis50%. When the unevaluable
egments were considered to represent significant disease,
5 patients were categorized as having significant CAD.
TP inducible defects were identified in 34 patients and in
6 (15%) of the vascular territories; 190 segments had
denosine-induced subendocardial (88%) or transmural
12%) perfusion defects. CTP had good intraobserver
kappa 0.66) and interobserver agreement (kappa 0.44)
Figure 2 MDCT Integrated Protocol Interpretative Algorithm
The MDCT integrated protocol (IP) was classified positive if a definitive luminal obs
if a perfusion defect was detected on computed tomography coronary perfusion (C
deemed negative if no stenosis50% were detected on CTA or if no perfusion def
coronary artery disease. MDCT  multidetector computed tomography.in per-patient analysis.FFR results. Fifty-four patients with visually perceived
diameter stenosis 40% were considered for FFR assess-
ment. Arteries without any identifiable plaque (n  179) or
with mild (40%) disease (n  29) had no FFR measure-
ments. Vessels with a luminal diameter 2 mm (n  10)
were also excluded. There were 19 completely occluded
arteries and 11 subtotally occluded arteries in which FFR
could not be measured but regarded as positive. Addi-
tionally, in 9 vessels with long sections of severe disease
and heavily calcified lesions associated with tortuous
anatomy and/or low TIMI-flow after intracoronary ni-
trates, FFR assessment was considered an unacceptable
risk and was not performed. Furthermore, in 5 patients
with LM disease FFR was not performed in any vessel of
the left coronary. Lesions in which FFR could not be
measured because of anatomy or disease complexity were
considered positive for the purpose of the comparison
with CMR-Perf and CTP. A total of 36 diseased,
unoccluded vessels (n  27) were evaluated using FFR
assessment. Using this approach, 72 arteries were classi-
fied as positives. Single-vessel disease was seen in 24
patients; 12 had double-vessel disease and 8 had triple-
n (50%) was detected on computed tomography coronary angiography (CTA) or
a territory corresponding to a lesion of uncertain significance on CTA. The IP was
ere found in areas supplied by vessels with uncertain findings on CTA. CAD tructio
TP) in
ects wvessel disease.
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CMR Versus MDCT Perfusion for Detection of CAD March 12, 2013:1099–107Figure 3 Five Cases Illustrating CMR-Perf, CTP, and Angiographic Findings in Patients With CAD
(A) Stress cardiac magnetic resonance perfusion (CMR-Perf) shows inducible ischemia in the septum and anterior wall (arrow shows dark area of hypoperfusion). Com-
puted tomography coronary perfusion (CTP) is concordant and x-ray invasive coronary angiography (xA) confirms a stenosis (arrowhead) in the LAD. (B) Both CMR-Perf
and CTP show a dark area of fixed hypoperfusion (arrows) in the inferior and inferoseptal wall, corresponding to an occluded right coronary artery as seen on xA.
(C) Both CMR-Perf and CTP were able to identify the reversible hypoperfusion (arrow) caused by a significant stenosis on the left circumflex artery. (D) Significant left
main disease as seen on xA (arrowhead) causing hypoperfusion on both left anterior descendent and left circumflex territories (arrows) on CMR-Perf and CTP. (E) Inter-
mediate (70%) stenosis in the mid left anterior descendent artery (arrowhead) causing functional ischemia detected by CMR-Perf and CTP (arrows) and confirmed using
fractional flow reserve (FFR  0.76).
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mances are summarized in Table 2. Of the 46 patients with
positive CMR-Perf scan, 39 had functionally significant
AD in at least 1 vessel. Of the 55 patients with normal
MR-Perf scans, 50 were true-negatives. CMR-Perf had
ery good sensitivity (89%) and specificity (88%). PPV and
PV were 85%, and 91%, respectively.
Isolated CTA analysis had an excellent sensitivity and
PV (100%) for detection of functionally significant CAD.
owever, specificity and PPV were low (61% and 67%,
espectively). CTP, conversely, had higher specificity (93%)
ith lower sensitivity (68%; p  0.001 for both). The
integrated MDCT protocol that results from integration of
functional data from CTP with the anatomic data from
CTA when the later is not sufficient for a confident
diagnosis (Fig. 2) had a sensitivity of 89%, and specificity of
83%. This represents a significant increase of specificity
(p  0.005) with a nonsignificant decreased sensitivity (p 
0.06). The overall accuracy for functional significant CAD
detection was 78% for CTA, 82% for CTP and 85% for the
MDCT integrated protocol.
C-statistics for detection of functionally significant CAD
were similar for CMR-Perf (AUC  0.88, 95% CI: 0.81 to
0.96) and MDCT-IP (AUC  0.86, 95% CI: 0.77 to 0.93;
p  0.52). They had the same sensitivity (89%) and
nonsignificant differences in specificity (88% vs. 83%, p 
0.61). Isolated CTP (AUC  0.81, 95% CI: 0.71 to 0.90)
tends to perform worse than CMR-Perf (p  0.06), having
similar specificity (93% vs. 88%, p  0.51) but significantly
inferior sensitivity (68% vs. 89%, p  0.005). CMR-Perf
had the best performance in discriminating functional
relevance of CAD in patients with stenosis 40% (AUC 
0.84, 95% CI: 0.72 to 0.93). Its performance in this
subgroup of 54 patients was superior to CTA (AUC 
0.60, 95% CI: 0.46 to 0.73; p  0.03), but nonsignificantly
superior to CTP (AUC  0.79, 95% CI: 0.66 to 0.89; p 
0.34). CTP was clearly superior to CTA in this setting (p
Comparison of Diagnostic Protocols in Predicting Functionally SignTable 2 Comparison of Diagnostic Protocols in Predicting Func
CAD (%) n TP TN FP FN k
% Se
(95%
Patient-based
CTA alone 43.6 101 44 35 22 0 0.58 100 (9
CTP alone 43.6 101 30 53 4 14 0.62 68 (5
MDCT Int to
Prot
43.6 101 39 47 10 5 0.70 89 (7
CMR-Perf 43.6 101 39 50 7 5 0.76 89 (7
Vessel-based
CTA alone 24.1 303 69 155 75 4 0.47 95 (8
CTP alone 24.1 303 40 219 11 33 0.56 55 (4
MDCT Int-Prot 24.1 303 52 206 24 21 0.60 71 (6
CMR-Perf 24.1 303 58 215 15 15 0.73 79 (7
Values for sensitivity, specificity, PPV, and NPV and accuracy are presented with 95% CI.
Accu.  accuracy; CAD  coronary artery disease; CTA  computed tomography angiography; C
alse-positive; Int-Prot  integrated protocol; k  kappa value; MDCT  multidetector compute
redictive value; Sensit.  sensitivity; Specif.  specificity; TN  true negative; TP  true positive0.02). When only the 67 patients with intermediate pre-test eprobability were analysed similar results were found: inte-
gration of CTP with CTA significantly increased MDCT
specificity from 63 to 85% (p  0.004) and accuracy was
similar for MDCT-IP and CMR-Perf (87% vs. 88%,
p  1.0).
Vessel-based analysis. A total of 303 vessels (n  101)
were analyzed. CMR-Perf had the best performance for
functionally significant CAD detection (AUC  0.87, 95%
CI: 0.82 to 0.90), clearly outperforming CTP (AUC 
0.75, 95% CI: 0.70 to 0.85; p  0.0003) but not CTA
(AUC  0.81, 95% CI: 0.75 to 0.85) or MDCT-IP (AUC 
0.80, 95% CI: 0.75 to 0.85), despite the tendency found
(p  0.08 for both). Furthermore, the MDCT-IP (p 
0.05) but not isolated CTA (p  0.09) performed signifi-
cantly better than isolated CTP. When only vessels that
effectively received FFR assessment were considered for
analysis, a nonsignificant tendency favouring CMR-Perf
over the MDCT-IP was seen (AUC  0.75 vs. 0.58,
respectively, p  0.06). In this particular case, CTP and
CTA performances did not differ significantly (AUC 
0.65 for both, p  0.99) with a clear advantage of CTA in
terms of sensitivity (95% vs. 42%, p  0.002) and of CTP
n terms of specificity (88% vs. 35%, p  0.004).
TP using CMR-Perfusion as a reference standard.
TP performance in detecting reversible myocardial isch-
mia having CMR-Perf as reference standard is presented
n Table 3. In per-patient analysis, isolated CTP had good
verall accuracy (82%) in identifying inducible perfusion
efects visualized on CMR-Perf, with a sensitivity of 67%
nd specificity of 95%. PPV was 91% and NPV 78%.
oninferiority analysis. Using either the C-statistic or the
ccuracy analysis results for the noninferiority analysis, an
1% noninferiority limit would be needed to conclude for
he noninferiority of MDCT-IP in comparison with CMR-
erf. For the present sample size, and for a nominal
ignificance level of 0.05, the 11% noninferiority limit was
t CAD (FFR <0.80)lly Significant CAD (FFR <0.80)
% Specif.
(95% CI)
% PPV
(95% CI)
% NPV
(95% CI) LR LR
% Accu.
(95% CI)
) 61 (55–61) 67 (61–67) 100 (89–100) 2.59 0.00 78 (71–78)
93 (85–98) 88 (75–96) 79 (72–83) 9.72 0.34 82 (73–87)
83 (74–88) 80 (70–86) 90 (82–96) 5.05 0.14 85 (76–91)
88 (80–93) 85 (75–91) 91 (83–96) 7.22 0.13 88 (79–94)
67 (65–69) 48 (44–50) 97 (94–99) 2.90 0.08 74 (70–76)
95 (93–97) 78 (66–88) 87 (84–89) 11.46 0.47 85 (81–89)
90 (87–92) 68 (59–76) 91 (88–93) 6.83 0.32 85 (81–89)
93 (91–96) 79 (71–86) 93 (91–96) 12.18 0.22 90 (86–93)
omputed tomography perfusion; CMR  cardiac magnetic resonance; FN  false-negative; FP 
graphy; Perf  myocardial perfusion imaging; PPV  positive predictive value; NPV  negative
positive likelihood ratio; LR  negative likelihood ratio.ificantiona
nsit.
CI)
2–100
8–74)
8–95)
9–95)
7–98)
6–61)
2–79)
1–86)
TP  cstimated with a power of 81.8%. Thus, based on our
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pared to MDCT-IP can be confidently excluded.
Discussion
This is the first study to directly compare CTP against
CMR-Perf using FFR as reference standard. Our main
findings are: 1) both CMR-Perf and MDCT-IP have an
excellent sensitivity and very good specificity for the detec-
tion of functionally significant CAD and their overall
performances are similar; 2) isolated CTP is globally inferior
to CMR-Perf for diagnosis of CAD but is very specific; and
3) addition of CTP to CTA increases MDCT global
accuracy for functionally significant CAD detection in
patients with intermediate to high pre-test probability,
mainly because of a significant increase in specificity. Thus,
a 64-MDCT morphologic and functional integrated proto-
col using standard available hardware and software may be
as effective as CMR-Perf standard protocols for detection of
functionally significant CAD.
Previous smaller studies compared CTP with SPECT or
CMR using QCA or visual estimation of stenosis severity as
the gold standard (21–23). Only one study compared CTP
against FFR in patients with known CAD (24). Evidence
shows that patients should be guided by the physiological
importance of a stenosis rather than luminal assessment and
FFR has emerged as the reference invasive tool to provide this
information (12).
Of note, in our study, both MDCT and CMR results were
obtained using standard acquisition protocols available in
current clinical MDCT and MR scanners. Tube voltage
limitation to a maximum of 100 kV, strict tube current
modulation in the stress scans and the use of prospective
scanning at rest resulted in a low radiation exposure (lower
than in previous 64-MDCT studies) (7,8,25). Based on our
results, low-dose perfusion protocols might be ready for rou-
tine use in clinical practice, without a significant increase of
radiation exposure, using standard 64-MDCT scanners: the
entire MDCT protocol, including Calcium-scoring, CTA and
CTP is completed with an effective radiation exposure that
represents less than one half of the exposure usually reported
for SPECT (21).
CMR-Perf results are in line with published studies and the
excellent accuracy of the method in symptomatic intermediate-
to-high risk patients is confirmed. Stress and rest perfusion
were simultaneously visualized with LGE images resulting in
very good accuracy for ischemia detection. Interestingly, inte-
Analysis of CTP in Predicting Reversible Perfusion Defects as AsseTable 3 Analysis of CTP in Predicting Reversible Perfusion Def
CAD (%) n TP TN FP FN k
% S
(95
Patient-based 45.5 101 31 52 3 15 0.82 67 (5
Vessel-based 24.1 303 40 219 11 33 0.56 55 (4
Values for sensitivity, specificity, PPV, and NPV and accuracy are presented with 95% CI.
Abbreviations are as in Table 2.gration of isolated ischemic scar detection as a marker of CADin the CMR-Perf interpretation algorithm did not improve
overall performance for functionally significant CAD detection
(data not shown). CMR has several advantages over MDCT
for the detection of myocardial ischemia: it does not expose
patients to ionizing radiation and provides dynamic real-time
imaging of myocardial perfusion over the first-passage of
contrast (26). MDCT perfusion is limited to the “one-shot”
opportunity to visualize differences of x-ray attenuation be-
tween the ischemic and remote myocardium. However, a
previous study evaluating myocardial blood flow quantification
showed that the difference in upslope between ischemic and
normal myocardium remains relatively constant for several
seconds during the entire arterial phase, after a minimum
delay of 12 s (27). Our imaging time point was chosen to be
within this constant wash-in phase. A potential advantage
of CTP over CMR is the ability to acquire high-resolution
isotropic 3D “whole heart” datasets that allow for simulta-
neous coronary anatomy and myocardial perfusion analysis.
This may be of particular interest for decision and manage-
ment of revascularization.
Isolated CTP results are also in line with previous studies.
However, a slightly lower sensitivity is noticed in our study.
This could be justified by scanner limitations in this low-
radiation 64-MDCT protocol. Simultaneously, a lower rate of
false positives is noticed, resulting in higher specificity. CTP
performed equally well in patients with or without ischemic
scar revealing that it is capable of detecting perfusion defects
that represent true ischemia and not only scar (data not
shown). Furthermore, CTP performance in discriminating
functionally relevant CAD in patients with stenosis 40% as
assessed by xA was clearly superior to CTA. We have recently
shown that the addition of CTP to CTA improves diagnostic
accuracy of MDCT as assessed by invasive QCA, mainly
because of an increased specificity in heavily calcified coronary
arteries (15). Not surprisingly, the use of a functional standard
in current study confirms this finding and highlights the
advantage of functional and anatomic integration.
CTP intra- and interobserver agreement was only mod-
erate and self-reported confidence was lower compared with
CMR. This is an expected finding, as CMR-Perf is a
well-validated, clinically implemented and better-established
technique. The use of a new technique, despite the similarities,
involves a certain degree of uncertainty and a learning curve
that may explain the results.
Study limitations. Several limitations may decrease gener-
alizability of findings: single-center study, exclusion of
by CMR-Perfas Assessed by CMR-Perf
% Specif.
(95% CI)
% PPV
(95% CI)
% NPV
(95% CI) LR LR
% Accu.
(95% CI)
95 (86–99) 91 (78–98) 78 (71–81) 12.36 0.34 82 (73–87)
95 (93–97) 78 (66–88) 87 (84–89) 11.46 0.47 85 (81–89)ssedects
ensit.
% CI)
8–72)
6–61)patients with known CAD or low pre-test probability and of
11
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
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atrial fibrillation. The latter may be present in a significant
proportion of patients with suspected CAD (20% of study
exclusions) and is unclear which test is more susceptible to
this arrhythmia. The studied population may not be reflec-
tive of the usual population sent for CTA or stress testing as
only symptomatic intermediate/high pre-test probability
patients were recruited, including high-risk patients that
are not usually referred for stress-testing but rather
directly to xA. To address this issue, a subanalysis
exclusively including patients with intermediate pre-test
probability was performed.
FFR was only measured in vessels with intermediate steno-
ses and a significant proportion of diseased vessels had to be
excluded from this evaluation. While this was performed to
avoid potential iatrogenic complications, an eventual bias may
exist. To minimize this limitation, a subanalysis of vessels with
an effective FFR assessment was performed.
The MDCT protocol was based on a single-source 64-
MDCT scanner with its known technical limitations, such as
low temporal resolution and misalignment artifacts, which may
be overcome with more advanced technology. However, it is
important to note that low dose CTP imaging is available
today and yields important information missed by CTA alone.
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